cbdMD (YCBD) Total Non-Current Liabilities (2016 - 2025)
cbdMD's (YCBD) quarterly Total Non-Current Liabilities came in at $201235.0 in Q2 2025, down 93.2% year-on-year from $3.0 million in Q2 2024, and down 49.71% quarter-over-quarter from $400144.0 in Q1 2025.
cbdMD (YCBD) Total Non-Current Liabilities (2016 - 2025) Analysis & Trends
cbdMD has disclosed Total Non-Current Liabilities across 10 years of filings, most recently posting $201235.0 for Q2 2025.
- Total Non-Current Liabilities for Q2 2025 came in at $201235.0, down 93.2% year-over-year; the trailing twelve-month figure through Jun 2025 was $201235.0 (down 93.2% YoY), and the FY2023 annual result was $2.5 million, down 38.91% from the prior year.
- Total Non-Current Liabilities came in at $201235.0 for Q2 2025 at cbdMD, down from $400144.0 in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $28.3 million in Q1 2021 to a low of $201235.0 in Q2 2025.
- The 5-year median for Total Non-Current Liabilities is $3.6 million (2022), against an average of $6.5 million.
- Across the five-year window, Total Non-Current Liabilities soared 93.46% in 2021 and plunged 93.2% in 2025, its largest moves.
- cbdMD's Total Non-Current Liabilities stood at $8.2 million in 2021, then sank by 56.11% to $3.6 million in 2022, then sank by 41.77% to $2.1 million in 2023, then sank by 71.65% to $591583.0 in 2024, then plunged by 65.98% to $201235.0 in 2025.
- The last three Total Non-Current Liabilities figures came in at $201235.0 (Q2 2025), $400144.0 (Q1 2025), and $591583.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.81 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | cbdMD | 3,884.57 | -3.38 Mn | 3.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 201,235.00 |
| Mar 31, 2025 | 400,144.00 |
| Dec 31, 2024 | 591,583.00 |
| Jun 30, 2024 | 2.96 Mn |
| Mar 31, 2024 | 4.53 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Sep 30, 2023 | 2.49 Mn |
| Jun 30, 2023 | 2.85 Mn |
| Mar 31, 2023 | 3.22 Mn |
| Dec 31, 2022 | 3.58 Mn |
| Sep 30, 2022 | 4.08 Mn |
| Jun 30, 2022 | 4.81 Mn |
| Mar 31, 2022 | 7.18 Mn |
| Dec 31, 2021 | 8.17 Mn |
| Sep 30, 2021 | 14.82 Mn |
| Jun 30, 2021 | 19.49 Mn |
| Mar 31, 2021 | 28.31 Mn |
| Dec 31, 2020 | 31.62 Mn |
| Sep 30, 2020 | 23.97 Mn |
| Jun 30, 2020 | 23.34 Mn |